Inventor
DAI XING
CN47 patents
⚠️ This page may combine multiple inventors who share the name “DAI XING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INVENTISBIO CO LTD
15 patentsUS11091481B2Aug 17, 2021
Heterocyclic compounds, preparation and methods and uses thereof
INVENTISBIO CO LTD5 citations83
US12492184B2Dec 9, 2025
Heteroaryl compounds, preparation methods and uses thereof
INVENTISBIO CO LTD0 citations62
US12227491B2Feb 18, 2025
EGFR inhibitors
INVENTISBIO CO LTD0 citations62
US11903931B2Feb 20, 2024
Salts of selective estrogen receptor degraders
INVENTISBIO CO LTD0 citations62
US11685720B2Jun 27, 2023
Salt forms of URAT-1 inhibitors
INVENTISBIO CO LTD0 citations62
US11639344B2May 2, 2023
EGFR inhibitors
INVENTISBIO CO LTD0 citations62
US12509448B2Dec 30, 2025
Salts of indoleamine 2,3-dioxygenase inhibitors
INVENTISBIO CO LTD0 citations61
US12246020B2Mar 11, 2025
Heterocyclic compounds, preparation methods and uses thereof
INVENTISBIO CO LTD0 citations61
US11865115B2Jan 9, 2024
Heterocyclic compounds, preparation methods and uses thereof
INVENTISBIO CO LTD0 citations61
US11241437B2Feb 8, 2022
Heterocyclic compounds, preparation methods and uses thereof
INVENTISBIO CO LTD0 citations61
US12391677B2Aug 19, 2025
Thyroid hormone receptor agonists
INVENTISBIO CO LTD0 citations59
US12173010B2Dec 24, 2024
Heterocyclic compounds, preparation methods therefor, and methods of uses thereof
INVENTISBIO CO LTD0 citations57
US12110289B2Oct 8, 2024
Heterocyclic compounds, preparation methods and uses thereof
INVENTISBIO CO LTD0 citations57
US11691981B2Jul 4, 2023
Heterocyclic compounds, preparation methods therefor, and methods of uses thereof
INVENTISBIO CO LTD0 citations57
US12427146B2Sep 30, 2025
C-terminal SRC kinase inhibitors
INVENTISBIO CO LTD0 citations49
MERCK SHARP & DOHME
14 patentsUS9718818B2Aug 1, 2017
Compounds inhibiting leucine-rich repeat kinase enzyme activity
MERCK SHARP & DOHME25 citations93
US9364482B2Jun 14, 2016
Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases
MERCK SHARP & DOHME8 citations84
US9243002B2Jan 26, 2016
Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C
MERCK SHARP & DOHME8 citations83
US10689401B2Jun 23, 2020
C5-C6-oxacyclic fused iminothiazine dioxide compounds bearing an ether linker as BACE inhibitors, compositions, and their use
MERCK SHARP & DOHME2 citations72
US11008338B2May 18, 2021
C5-C6-oxacyclic fused iminothiazine dioxide compounds bearing an ether linker as BACE inhibitors, compositions, and their use
MERCK SHARP & DOHME0 citations62
US10047098B2Aug 14, 2018
C5-C6-oxacyclic fused iminopyrimidinone compounds as bace inhibitors, compositions, and their use
MERCK SHARP & DOHME1 citations52
US9688654B2Jun 27, 2017
Compounds inhibiting leucine-rich repeat kinase enzyme activity
MERCK SHARP & DOHME1 citations51
US8361959B2Jan 29, 2013
Spiro-imidazolone derivatives as glucagon receptor antagonists
MERCK SHARP & DOHME2 citations51
US9809568B2Nov 7, 2017
Compounds inhibiting leucine-rich repeat kinase enzyme activity
MERCK SHARP & DOHME1 citations50
US10954240B2Mar 23, 2021
Compounds inhibiting leucine-rich repeat kinase enzyme activity
MERCK SHARP & DOHME0 citations48
US9440952B2Sep 13, 2016
Compounds inhibiting leucine-rich repeat kinase enzyme activity
MERCK SHARP & DOHME1 citations48
US10604534B2Mar 31, 2020
C5-C6-oxacyclic fused iminothiadiazine dioxide compounds bearing an ether linker as BACE inhibitors, compositions, and their use
MERCK SHARP & DOHME0 citations42
US9745324B2Aug 29, 2017
Iminothiadiazepane dioxide compounds as BACE inhibitors, compositions, and their use
MERCK SHARP & DOHME0 citations42
US9493461B2Nov 15, 2016
Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C
MERCK SHARP & DOHME0 citations40
MCCOMAS CASEY C
3 patentsUS9265773B2Feb 23, 2016
Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases
MCCOMAS CASEY C8 citations82
US9573939B2Feb 21, 2017
Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases
MCCOMAS CASEY C6 citations71
US9549917B2Jan 24, 2017
Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases
MCCOMAS CASEY C1 citations50
INVENTISBIO LLC
3 patentsUS10980807B2Apr 20, 2021
Inhibitor of indoleamine-2,3-dioxygenase (IDO)
INVENTISBIO LLC5 citations70
US12187736B2Jan 7, 2025
Selective estrogen receptor degraders and uses thereof
INVENTISBIO LLC0 citations60
US11969425B2Apr 30, 2024
Inhibitor of indoleamine-2,3-dioxygenase (IDO)
INVENTISBIO LLC0 citations60
BEIJING SENSETIME TECH DEVELOPMENT CO LTD
2 patentsUS11205284B2Dec 21, 2021
Vehicle-mounted camera pose estimation method, apparatus, and system, and electronic device
BEIJING SENSETIME TECH DEVELOPMENT CO LTD7 citations84
US11069088B2Jul 20, 2021
Visual positioning method and apparatus, electronic device, and system
BEIJING SENSETIME TECH DEVELOPMENT CO LTD0 citations52